Geode Capital Management
EPRS

Geode Capital Management’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Geode Capital Management’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-82,821
Closed -$37K – 4132
2016
Q2 		$37K Hold
82,821
– – ﹤0.01% 3974
2016
Q1 		$222K Sell
82,821
-111
-0.1% -$312 ﹤0.01% 3599
2015
Q4 		$256K Buy
82,932
+222
+0.3% +$1K ﹤0.01% 3583
2015
Q3 		$365K Buy
82,710
+7,763
+10% +$45.6K ﹤0.01% 3379
2015
Q2 		$427K Buy
74,947
+10,708
+17% +$73.1K ﹤0.01% 3272
2015
Q1 		$574K Buy
64,239
+43,456
+209% +$349K ﹤0.01% 3141
2014
Q4 		$117K Hold
20,783
– – ﹤0.01% 3752
2014
Q3 		$149K Buy
+20,783
New +$180K ﹤0.01% 3657

Other funds holding EPRS

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Geode Capital Management's EPRS Position: Q3 2016 in Review

Geode Capital Management sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 82,821 shares — an estimated $37K sold.

Geode Capital Management first reported a position in EPRS in Q3 2014 and held it in 8 quarters. The position peaked at $574K in Q1 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

  • Geode Capital Management reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
  • Geode Capital Management sold 82,821 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $37K.
  • Geode Capital Management first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 8 quarters.
  • Geode Capital Management's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $574K in Q1 2015.
  • 3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Geode Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.